From Medical Xpress:
'Pay-for-performance' may lead to higher risk for robotic prostate surgery patients.
Here's the link: medicalxpress.com/news/2015-03-pay-for-performance-higher-robotic-prostate-surgery.html
"A "perverse disincentive" for hospitals that have invested in expensive technology for robotic surgery may be jeopardizing prostate cancer patients who seek out the procedure, concluded a new study led by Henry Ford Hospital researchers."
•The number of hospitals performing RARP remained stable over the study period - 802 in 2009, 792 in 2010 and 808 in 2011.
•The overall complication rate after surgery was "significantly" related to the volume of RARPs performed at a hospital.
•14.7 percent of patients treated at very-low volume institutions experienced complications while those treated at very-high volume institutions experienced a complication rate of 5.7 percent.
•Patients treated at very-high volume hospitals were less than half as likely to experience a complication as those treated at very-low volume hospitals.
I'm only posted this for informational reasons only - again, nothing in this for me personally, just sharing news. . . . . .
57 yrs old, - DX'd PCa July '12
9 of 12 Gleason: 3+3 and 3+4
Negative DRE’s / NO / MO / T1C / Gland size 40gm / Vol. 22gm
Volume Study 8/14/12
Casodex 50mg daily 5 wks prior 2 wks post BT
LDR BT 9/21/12 – no issues, No SE's
3 mo PSA 12/12 0.48!
6 mo PSA 3/13 0.21!
9 mo PSA 6/13 0.30!
1 yr PSA 9/13 0.30!
18 mo PSA 3/14 0.30!
2 yr PSA 9/14 0.13!
2-1-2 yr PSA 3/15 0.12!